Recommended treatment options for prostate cancer vary based on disease severity and life expectancy, with traditional approaches including active surveillance, surgery, radiation therapy, chemotherapy, and androgen deprivation therapy (ADT). Prostate cancer that progresses despite ADT is known as castration-resistant prostate cancer (CRPC). Until recently, the standard of care for CRPC patients w ...
- Mobile + Online on QuantiaMD
This critical review of results presented at the December 2014 San Antonio Breast Cancer Symposium includes neoadjuvant and adjuvant therapy, endocrine plus targeted strategies for early and metastatic disease, triple negative and anti-HER2 subtype updates, immune therapy, presurgical window trials, translational science, local-regional disease, prevention and survivorship. AGENDA New Direct ...
- Online Presentation